SEC Form 4/A · accession 0001209191-17-040603
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
George Frederick John Gosbee
Director
Period of report
Jun 7, 2017
Accepted (ET)
Jun 16, 2017 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $0.73 | holding | — | — | — | — | Jun 7, 2027 | Common Stock | 140,816 | 140,816 | D |
Explanation of responses
- F125% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.
- F2This filing is to correct the number of options granted on June 7, 2017 to 140,816. All other information remain the same.